Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smarter Follow-Up could boost CPAP use and cut costs

NCT ID NCT04559737

Disease control Sponsor: Kaiser Permanente Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study compares two approaches to help people with moderate-to-severe obstructive sleep apnea stay on CPAP therapy. One group receives usual care, where patients reach out if they have trouble. The other group adds active monitoring and extra support only for those who struggle, while successful users are left alone. The goal is to see which method improves CPAP adherence and is more cost-effective over one year.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
case management (population management platform with management by exception follow-up)
What this could lead to
If successful, this approach could improve CPAP adherence and reduce healthcare costs by focusing resources on patients who need help most.
What could go wrong
This is a small, early-stage study comparing care models, not testing a new treatment. Results may not apply to other healthcare systems or patient populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Expected to start

Jul 2020

An estimate. Start dates often move.

Finished

Jul 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Kaiser Permanente member * Moderate-Severe Obstructive Sleep Apnea diagnosis (AHI4%≥15 on home sleep apnea test \[Nox T3 or WatchPAT\] or polysomnography (in-lab study) * PAP therapy clinically recommended and prescribed for home therapy of OSA * Adults (age ≥ 18 years) Exclusion Criteria: * Chronic respiratory failure requiring bilevel PAP ventilatory support or addition of oxygen supplementation. * Prior use of PAP prescribed for home therapy. * Inability wirelessly connect patient's PAP device.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obstructive sleep apnea (OSA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome Patient Participation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Obstructive sleep apnea (OSA)

Contacts and locations

Locations

  • Kaiser Permanente Sleep Center

    Fontana, California, 92335, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.